The 2011 EU Technology Innovation Award in Bioprocessing is presented to France-based Sartorius Stedim in recognition of being the only company headquartered in Europe able to cater to the modern biotechnology industry with innovative solutions, including its pioneering single use bioreactor systems.
Sartorius Stedim has been able to manufacture single use reactors at various scales. Depending on the single use bioreactor type the current range extends from 1-2 litre systems up to 300L, while 500L, 1000L and 2000L systems are in the pipeline. Each of these reactors is available as standard or custom solutions and is designed to suit client requirements.
"Even though the majority of single use bioreactor systems are geared towards the production of high value active pharmaceutical molecules, the system can also be used for other application areas as well, such as biologically derived petrochemicals," notes Frost & Sullivan Research Analyst Krishna Venkataramani.
In addition to pharmaceutical and petrochemical applications, a single use bioreactor can be used in food-based and generic microbial fermentative processes as well. While most companies sell single use reactor in single type of agitation technology, Sartorius Stedim has a variety of technologies which can be used according to the need of the application.
"For instance, for mammalian cell lines which require low shear, wave mixing is suitable, while for less shear sensitive mammalian cell lines or for fermentation with microbes, an impeller based mixing is most suitable," explains Venkataramani. "Sartorius Stedim offers both kinds of products depending on the type of reaction."
Fermentation is one of the ways to produce long chain carbon molecules (C6-C7). Such molecules are best suited as precursors for fuels and plastics and allied derivatives.
"Single use bioreactors are key in the scale-up of such reactions," remarks Venkataramani. "They play a major role in cost cutting and ensuring sterility during the scale-up stages."
Implementing single use bioreactors designed by Sartorius Stedim also offers monetary benefits. Apart from the obvious advantages related to reduced scale up and certification costs, Sartorius Stedim supports the long lifespan of its products through constant service and maintenance contracts.
"Compared to conventional bioreactors, single use bioreactors are relatively easy to manufacture as well as disassemble," concludes Venkataramani. "Single use bioreactors, such as those developed by Sartorius Stedim, are set to revolutionise the biotechnology industry and represent its future."
The Technology Innovation Award is presented to the company that has excelled in the following criteria: uniqueness of technology, impact on new products/applications, impact on functionality, impact on customer value and relevance of innovation to industry.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Sartorius Stedim
Sartorius Stedim Biotech (sartorius-stedim.com), a leader in providing new age equipment and services to its clients. They primarily serve the biopharmaceutical industry with precision and sterile equipment such as bioreactors, sensors, filtration systems and other such industrial scale equipment. They also supply laboratory grade and scale equipment for the same purposes. Currently, there is a huge focus on the company to cater to next generation processes. For this, they have developed state of the art single use technologies and value added service to meet the rapidly evolving climate and requirements of the industry. The company also has a strong technology backing through their well-staffed and trained R&D team who are able to output customized solutions based on case to case requirements. The company’s motto is "turning science into solutions" which they follow on a day to day basis. Sartorius Stedim Biotech is a company headquartered in Aubagne, France and is publicly listed. The company is global in its reach and has key development and sales facilities across the Atlantic.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.